AMU Scientists Secure Major Wins in Cancer Research and Renewable Energy
AMU Patents Affordable Anti-Cancer Drug; Prof Rehan Honored for Solar Energy Breakthrough
Aligarh Muslim University secures a patent for a low-cost anti-cancer drug developed by top chemists. Meanwhile, Prof. Mohammad Rehan wins the IEEE Hingorani Award 2025 for solar energy innovation. Read more about these landmark achievements.
In a remarkable scientific achievement, researchers at Aligarh Muslim University (AMU) have been granted a patent for a novel anti-cancer drug that could revolutionize cancer treatment. The breakthrough comes from the Department of Chemistry, where Prof. Farooq Arjmand, Dr. Zeenat Afshan, and Prof. Sartaj Tabassum led the research and development.
What sets this drug apart is its affordability and minimal side effects—traits that could make advanced treatment more accessible. The innovation reflects the cutting-edge work of Prof. Arjmand, an acclaimed scientist with over 7,000 citations, 196 publications, and an H-index of 42. Her accolades include the CRSI Bronze Medal and the ISCB Women Scientist Award.
The co-inventors, Dr. Afshan and Prof. Tabassum, are widely respected for their expertise in coordination chemistry and pharmaceutical formulations, which contributed to the drug’s precision and effectiveness.
Meanwhile, in a separate feat, Prof. Mohammad Rehan of AMU’s Electrical Engineering Department has been selected for the IEEE Power and Energy Society Hingorani Award 2025 for his leadership in solar photovoltaic innovation. As Director General of NISE and Chair of BIS’s Solar PV Committee, Prof. Rehan is playing a vital role in shaping India’s renewable energy landscape.
At AMU, his initiatives are turning the campus into a model of sustainable energy transformation.
